Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Todos Medical Ltd's Business Segments
Todos Medical Ltd's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 2
Countrys Reported
2
Todos Medical Ltd does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Country - FY
- US100%
- IL0%
Revenue by Geographic Country - FY
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 2 | 100% |
| IL | - | 0% |
Description of Todos Medical Ltd
Todos Medical Ltd is a medical diagnostics company that specializes in the development, manufacturing, and marketing of state-of-the-art diagnostic solutions for cancer and other diseases. The company was founded in 2010 and is headquartered in Rehovot, Israel, with offices in New York, USA, and Beijing, China.
Todos Medical's core focus is on the development of blood tests that can detect cancer at its earliest stages. They aim to revolutionize cancer diagnostics by providing healthcare professionals with accurate and reliable tools that can improve patient outcomes. The company uses its proprietary Total Biochemical Infrared Analysis (TBIA) technology, which combines spectroscopy, artificial intelligence, and biochemistry to analyze blood samples and identify specific biomarkers associated with cancer.
Todos Medical's product portfolio includes a range of diagnostic platforms and assays for various types of cancer, including breast, lung, colon, and prostate cancer. Their tests are designed to be non-invasive and can be easily integrated into routine patient care. The company also offers comprehensive genetic profiling services, allowing healthcare providers to personalize treatment plans based on an individual's unique genetic makeup.
In addition to cancer diagnostics, Todos Medical has expanded its focus to include the diagnosis and management of COVID-19. They have developed a rapid point-of-care test called Tollovid™, which can detect the presence of the SARS-CoV-2 virus in less than an hour. This test is designed to be cost-effective, accessible, and highly accurate, allowing for efficient screening and monitoring of COVID-19.
Todos Medical operates in collaboration with leading academic and research institutions worldwide, including the Mayo Clinic and Columbia University. They have also established partnerships with biotech and pharmaceutical companies to accelerate the development and commercialization of their diagnostic products. The company's commitment to scientific excellence and collaboration has allowed them to build a robust pipeline of innovative solutions for the detection and management of cancer and infectious diseases.
Furthermore, Todos Medical has a strong global presence and is actively expanding its market reach. They have established distribution agreements in various countries, including the United States, Canada, Israel, China, and India. This allows them to deliver their diagnostic solutions to healthcare professionals and patients worldwide, addressing the pressing need for early and accurate disease detection.
Overall, Todos Medical Ltd is a cutting-edge medical diagnostics company at the forefront of cancer and infectious disease diagnostics. With their innovative technology, comprehensive product portfolio, and global partnerships, they are poised to make a significant impact in improving patient outcomes and transforming the field of diagnostic medicine.
Todos Medical's core focus is on the development of blood tests that can detect cancer at its earliest stages. They aim to revolutionize cancer diagnostics by providing healthcare professionals with accurate and reliable tools that can improve patient outcomes. The company uses its proprietary Total Biochemical Infrared Analysis (TBIA) technology, which combines spectroscopy, artificial intelligence, and biochemistry to analyze blood samples and identify specific biomarkers associated with cancer.
Todos Medical's product portfolio includes a range of diagnostic platforms and assays for various types of cancer, including breast, lung, colon, and prostate cancer. Their tests are designed to be non-invasive and can be easily integrated into routine patient care. The company also offers comprehensive genetic profiling services, allowing healthcare providers to personalize treatment plans based on an individual's unique genetic makeup.
In addition to cancer diagnostics, Todos Medical has expanded its focus to include the diagnosis and management of COVID-19. They have developed a rapid point-of-care test called Tollovid™, which can detect the presence of the SARS-CoV-2 virus in less than an hour. This test is designed to be cost-effective, accessible, and highly accurate, allowing for efficient screening and monitoring of COVID-19.
Todos Medical operates in collaboration with leading academic and research institutions worldwide, including the Mayo Clinic and Columbia University. They have also established partnerships with biotech and pharmaceutical companies to accelerate the development and commercialization of their diagnostic products. The company's commitment to scientific excellence and collaboration has allowed them to build a robust pipeline of innovative solutions for the detection and management of cancer and infectious diseases.
Furthermore, Todos Medical has a strong global presence and is actively expanding its market reach. They have established distribution agreements in various countries, including the United States, Canada, Israel, China, and India. This allows them to deliver their diagnostic solutions to healthcare professionals and patients worldwide, addressing the pressing need for early and accurate disease detection.
Overall, Todos Medical Ltd is a cutting-edge medical diagnostics company at the forefront of cancer and infectious disease diagnostics. With their innovative technology, comprehensive product portfolio, and global partnerships, they are poised to make a significant impact in improving patient outcomes and transforming the field of diagnostic medicine.
Todos Medical Ltd. is a clinical-stage biotechnology company primarily engaged in the development of medical diagnostic products with a focus on early detection of cancer and other significant diseases. The companys core segments, products, and services revolve around innovative technologies aimed at improving health outcomes through early diagnosis.
Segments
1. Clinical Diagnostics: This segment is focused on developing and marketing diagnostic tests for cancer detection. The goal is to provide healthcare professionals with tools that facilitate early identification of various malignancies, thereby improving patient prognoses.
2. Research and Development (R&D): Todos Medical invests significantly in R&D to advance its product pipeline. This includes both pre-clinical and clinical studies to validate the effectiveness and reliability of its diagnostic solutions.
3. Laboratory Services: The company also operates laboratory facilities where tests are processed. These labs employ advanced techniques and methodologies to ensure accurate and timely results.
4. Consultation and Support Services: In addition to diagnostic testing, Todos Medical offers consultation services that aid healthcare providers in interpreting test results and implementing appropriate clinical actions based on those results.
Products
1. Cancer Diagnostic Tests: Todos Medical develops a range of blood-based tests designed to detect proteins, biomarkers, and other indicators associated with various types of cancer. These tests aim to offer non-invasive and accurate assessments, facilitating earlier intervention.
- TMB-1: One of the primary products in the testing portfolio, TMB-1 is designed for the detection of certain cancer types. It utilizes advanced biomarker technology to analyze genetic material and proteins related to tumor activity.
2. COVID-19 and Infectious Disease Testing: In response to the global pandemic, the company expanded its offerings to include testing for COVID-19. These tests utilize PCR and antigen detection methodologies to assess viral loads in patients.
3. Supportive Testing Solutions: Todos Medical also provides a suite of tests that support oncologists in treatment decisions and monitoring disease progression. This includes tests for assessing the effectiveness of existing treatment plans through molecular profiling.
Services
1. Laboratory Testing Services: Todos Medical operates accredited laboratories that conduct various diagnostic tests. These services include sample collection, analysis, and reporting of results, with a focus on maintaining high-quality standards.
2. Consultative Services for Healthcare Providers: The company offers educational resources and support for healthcare professionals, helping them understand the applications and implications of diagnostic tests in clinical practice. This may include webinars, training sessions, and personalized consultations.
3. Clinical Trial Support: With a strong emphasis on R&D, Todos Medical engages in partnerships to support clinical trials aimed at validating new tests. They provide services such as trial design consultation, patient recruitment strategies, and regulatory guidance.
4. Data Analysis and Interpretation: Through its proprietary technologies, Todos Medical is equipped to analyze and interpret complex data derived from diagnostic tests. This service enhances the decision-making process for healthcare providers regarding patient care.
5. Regulatory Services: Given the highly regulated nature of medical diagnostics, Todos Medical also offers consulting services related to regulatory compliance, helping to navigate the appropriate frameworks for approvals and market entry.
Target Markets
Todos Medical Ltd. primarily targets oncology and infectious disease markets, collaborating with hospitals, clinics, and diagnostic laboratories. Their innovative solutions are directed towards improving patient outcomes in terms of early detection and efficient treatment pathways.
Future Developments
Todos Medical is committed to ongoing innovation in the diagnostics field. As part of their growth strategy, they aim to expand their product offerings, improve existing services, and continue conducting clinical studies to validate new diagnostic technologies.
In summary, Todos Medical Ltd. is significantly involved in enhancing healthcare through its pioneering diagnostic solutions and services, particularly in the realms of cancer detection and infectious disease testing. Their commitment to R&D, quality laboratory services, and healthcare provider support positions them as a notable player in the biotechnology sector.
Segments
1. Clinical Diagnostics: This segment is focused on developing and marketing diagnostic tests for cancer detection. The goal is to provide healthcare professionals with tools that facilitate early identification of various malignancies, thereby improving patient prognoses.
2. Research and Development (R&D): Todos Medical invests significantly in R&D to advance its product pipeline. This includes both pre-clinical and clinical studies to validate the effectiveness and reliability of its diagnostic solutions.
3. Laboratory Services: The company also operates laboratory facilities where tests are processed. These labs employ advanced techniques and methodologies to ensure accurate and timely results.
4. Consultation and Support Services: In addition to diagnostic testing, Todos Medical offers consultation services that aid healthcare providers in interpreting test results and implementing appropriate clinical actions based on those results.
Products
1. Cancer Diagnostic Tests: Todos Medical develops a range of blood-based tests designed to detect proteins, biomarkers, and other indicators associated with various types of cancer. These tests aim to offer non-invasive and accurate assessments, facilitating earlier intervention.
- TMB-1: One of the primary products in the testing portfolio, TMB-1 is designed for the detection of certain cancer types. It utilizes advanced biomarker technology to analyze genetic material and proteins related to tumor activity.
2. COVID-19 and Infectious Disease Testing: In response to the global pandemic, the company expanded its offerings to include testing for COVID-19. These tests utilize PCR and antigen detection methodologies to assess viral loads in patients.
3. Supportive Testing Solutions: Todos Medical also provides a suite of tests that support oncologists in treatment decisions and monitoring disease progression. This includes tests for assessing the effectiveness of existing treatment plans through molecular profiling.
Services
1. Laboratory Testing Services: Todos Medical operates accredited laboratories that conduct various diagnostic tests. These services include sample collection, analysis, and reporting of results, with a focus on maintaining high-quality standards.
2. Consultative Services for Healthcare Providers: The company offers educational resources and support for healthcare professionals, helping them understand the applications and implications of diagnostic tests in clinical practice. This may include webinars, training sessions, and personalized consultations.
3. Clinical Trial Support: With a strong emphasis on R&D, Todos Medical engages in partnerships to support clinical trials aimed at validating new tests. They provide services such as trial design consultation, patient recruitment strategies, and regulatory guidance.
4. Data Analysis and Interpretation: Through its proprietary technologies, Todos Medical is equipped to analyze and interpret complex data derived from diagnostic tests. This service enhances the decision-making process for healthcare providers regarding patient care.
5. Regulatory Services: Given the highly regulated nature of medical diagnostics, Todos Medical also offers consulting services related to regulatory compliance, helping to navigate the appropriate frameworks for approvals and market entry.
Target Markets
Todos Medical Ltd. primarily targets oncology and infectious disease markets, collaborating with hospitals, clinics, and diagnostic laboratories. Their innovative solutions are directed towards improving patient outcomes in terms of early detection and efficient treatment pathways.
Future Developments
Todos Medical is committed to ongoing innovation in the diagnostics field. As part of their growth strategy, they aim to expand their product offerings, improve existing services, and continue conducting clinical studies to validate new diagnostic technologies.
In summary, Todos Medical Ltd. is significantly involved in enhancing healthcare through its pioneering diagnostic solutions and services, particularly in the realms of cancer detection and infectious disease testing. Their commitment to R&D, quality laboratory services, and healthcare provider support positions them as a notable player in the biotechnology sector.